Elsevier

Seminars in Perinatology

Volume 31, Issue 6, December 2007, Pages 354-362
Seminars in Perinatology

Pregnancy After Thoracic Organ Transplantation

https://doi.org/10.1053/j.semperi.2007.09.005Get rights and content

A growing number of heart, heart–lung, or lung transplant recipients are women of reproductive age. Fertility and pregnancy are important issues in this group of patients and often pose complex medical, psychosocial, and ethical problems. Many successful pregnancy outcomes have been reported following heart or lung transplantation. Nevertheless, these patients are at risk of certain maternal, fetal, and neonatal complications, including hypertension, preeclampsia, infection, preterm birth, and low birth weight. The physiological changes that occur in pregnancy are generally well tolerated by patients who have undergone thoracic organ transplant(s). The risk of allograft rejection during and after pregnancy is significant, and it is important to maintain an adequate level of immunosuppression. Pregnancies among lung transplant recipients are at higher risk for certain complications. The rate for graft rejection, independent of pregnancy status, is higher in this population. The long-term graft and patient outcomes citing a 50% 5-year mortality will be critical while counseling these patients regarding the impact of pregnancy on survival, and the ability to participate in raising the child. A multi-disciplinary team, involving specialists in maternal fetal medicine, cardiology or pulmonary medicine, transplant medicine, anesthesiology, high-risk nursing, neonatology, psychology, genetics, and social service, is crucial to the care of these patients. This team approach should be initiated at the time of pretransplant and preconception counseling and be continued through the prenatal and postpartum periods. The management plan should be individualized according to the status of the mother, the fetus, and the allograft. For most cases, given the need for close collaboration and frequent monitoring, these patients are best managed at their primary transplant institution in collaboration with local or referring physicians.

Section snippets

References (46)

  • M.C. Deng et al.

    Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling

    Am J Transplant

    (2006)
  • L.M. Askie et al.

    Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data

    Lancet

    (2007)
  • K. Ueland et al.

    Maternal cardiovascular dynamicsII. Posture and uterine contractions

    Am J Obstet Gynecol

    (1969)
  • E.P. Trulock et al.

    Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report–2006

    J Heart Lung Transplant

    (2006)
  • D. Parry et al.

    Pregnancy following lung transplantation

    Transplant Proc

    (1997)
  • K.M. Gyi et al.

    Pregnancy in cystic fibrosis lung transplant recipients: case series and review

    J Cyst Fibros

    (2006)
  • O. Baron et al.

    Pregnancy and heart-lung transplantation

    J Heart Lung Transplant

    (2002)
  • E.P. Kirk

    Organ transplantation and pregnancyA case report and review

    Am J Obstet Gynecol

    (1991)
  • R. Ahner et al.

    [Pregnancy and spontaneous delivery 13 months after heart transplantation]

    Geburtshilfe Frauenheilkd

    (1993)
  • J.R. Scott et al.

    Pregnancy in heart transplant recipients: management and outcome

    Obstet Gynecol

    (1993)
  • S.A. Laifer et al.

    Pregnancy after cardiac transplantation

    Am J Perinatol

    (1994)
  • L.F. Ross

    Ethical considerations related to pregnancy in transplant recipients

    N Engl J Med

    (2006)
  • A. Morini et al.

    Pregnancy after heart transplant: update and case report

    Hum Reprod

    (1998)
  • Cited by (34)

    • Pregnancy After Heart Transplant

      2022, Maternal Cardiac Care: A Guide to Managing Pregnant Women with Heart Disease
    • Heart Transplantation in Women

      2019, Heart Failure Clinics
      Citation Excerpt :

      The etiology of the mother’s cardiomyopathy must be taken into consideration because some cardiac diseases are hereditary. For example, congenital heart disease has a recurrence rate of up to 8% in offspring, and familial cardiomyopathies with a genetic basis exist.13,14 Women with potentially inheritable conditions should undergo preconception genetic counseling.

    • Bioethical considerations

      2014, Best Practice and Research: Clinical Obstetrics and Gynaecology
    • Infertility and ART after transplantation

      2014, Best Practice and Research: Clinical Obstetrics and Gynaecology
    View all citing articles on Scopus
    View full text